Deal History
Om oss
Om oss
Team
Våra kontor
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Skuldrådgivning
Equity Research
Tillväxtkapital
IPO Advisory
Industries
Företagstjänster
Internet och konsumentprodukter
Industri och verkstad
Sjuk- och hälsovård
Mjukvara och TMT
Research
Analysmaterial
Makro och marknad
Career
Events
Insights
News
Bolagsnyheter
Deal News
I pressen
Newsletter
Kontakt
Newsletter
SV
INT
DE
Main menu button
Team
Deals
Kontakt
Aktieanalys
Team
Deals
Kontakt
Nyheter
Alla
Analysmaterial
Bolagsnyheter
Deal News
Events
I pressen
Insights
Makro och marknad
06 dec 2024
Carlsquare Consumer Conference 2025
Events
19 nov 2024
Equity research Nosa Plugs Q3, 2024: Strong growth with a rise in valuation on the cards
Analysmaterial
Nosa Plugs
14 nov 2024
Research update Biosergen: Promising interim data as BSG005 saves lives
Analysmaterial
Biosergen
08 nov 2024
Equity Research Nosa Plugs: First impression Q3, 2024
Analysmaterial
Nosa Plugs
04 nov 2024
A rebounding software market, driven by profitability and strategic M&A
Insights
18 okt 2024
Digital Health Report: Ongoing Dynamics in the VC and European M&A Market
Insights
11 okt 2024
Mastering Your SaaS Exit: Key Tips
Insights
23 sep 2024
Carlsquare Equity Research interview with Biosergen
Analysmaterial
Biosergen
12 sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Analysmaterial
Biosergen
29 aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Analysmaterial
Nosa Plugs
23 aug 2024
Equity Research Nosa Plugs: First impression Q2, 2024
Analysmaterial
Nosa Plugs
05 aug 2024
Government Technology Sector 2024 Update
Insights
05 jul 2024
Research update Biosergen: Taking the next clinical step
Analysmaterial
Biosergen
20 jun 2024
Equity Research Nosa Plugs: New orders and distributor agreements
Analysmaterial
Nosa Plugs
28 maj 2024
Carlsquare Consumer Conference 2024
Events
23 maj 2024
Ready to Launch: Industrial Tech IPO Market 2024
Insights
17 maj 2024
Equity research Nosa Plugs Q1, 2024: Tepid Q1 and updated company strategy
Analysmaterial
Nosa Plugs
13 mar 2024
Research update Biosergen: Rights issue to fund crucial step for lead project
Analysmaterial
Biosergen
07 mar 2024
Carlsquare Equity Research intervju med Biosergen (Engelska)
Analysmaterial
Biosergen
21 feb 2024
Analys Nosa Plugs kv4, 2023: Nytt försäljningsrekord stöttar forskning och utveckling
Analysmaterial
Nosa Plugs
1
2
3
4